Mirae Asset Global Etfs Holdings Ltd. Enanta Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 11,471 shares of ENTA stock, worth $73,873. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,471
Previous 10,931
4.94%
Holding current value
$73,873
Previous $113,000
42.48%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
19.7MCall Options Held
9.7KPut Options Held
12.4K-
Krensavage Asset Management, LLC New York, NY2.12MShares$13.6 Million7.2% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.11MShares$13.6 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$12.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$11.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.22MShares$7.87 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $133M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...